Community-acquired versus hospital-acquired methicillin-resistant Staphylococcus aureus in postoperative orthopaedic infections: A prospective observational study.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i6.1919Keywords:
Methicillin-resistant Staphylococcus aureus, Community-acquired, Hospital-acquired Methicillin-resistant Staphylococcus aureus, Orthopaedic infections, Surgical site infection, Antimicrobial resistance, Wound infectionAbstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant cause of postoperative orthopaedic infections worldwide. Differentiating community-acquired MRSA (CA-MRSA) from hospital-acquired MRSA (HA-MRSA) is critical for effective treatment, infection control, and public health planning.
Objective: This study aimed to compare the prevalence, clinical profiles, antibiotic susceptibility patterns, and outcomes of CA-MRSA and HA-MRSA infections in postoperative orthopaedic surgical site infections (SSIs).
Methods: A prospective observational study was conducted over 18 months in a tertiary care teaching hospital. Patients developing SSIs within 30 days after orthopaedic surgery were included. Wound swabs and pus samples were processed for culture and sensitivity testing. MRSA was identified by cefoxitin disc diffusion and mecA gene PCR. Cases were classified as CA-MRSA or HA-MRSA per CDC criteria. Clinical data, risk factors, antibiotic susceptibility, and outcomes were analysed.
Results: Among 146 SSI cases, MRSA was isolated in 57 (39.0%), with 24 (42.1%) CA-MRSA and 33 (57.9%) HA-MRSA. HA-MRSA cases had higher rates of prior hospitalization (78.8% vs. 20.8%, p<0.001), previous antibiotic use (66.7% vs. 25.0%, p=0.002), and comorbidities. CA-MRSA isolates were more susceptible to clindamycin (87.5%) and trimethoprim-sulfamethoxazole (79.2%) compared to HA-MRSA (51.5% and 36.4%). All isolates were uniformly sensitive to vancomycin and linezolid. HA-MRSA infections were linked to longer wound healing and hospital stays (p=0.01).
Conclusion: Both CA-MRSA and HA-MRSA contribute considerably to postoperative orthopaedic infections. HA-MRSA is more common and associated with worse clinical outcomes. Variations in susceptibility patterns highlight the importance of targeted empirical therapy and strict infection control measures.
Recommendations: Implement routine MRSA typing, reinforce antibiotic stewardship, enhance preoperative screening, and strengthen hospital hygiene practices to reduce MRSA burden and improve patient outcomes.
References
Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes in studies of antimicrobial resistance. Ann Intern Med. 2004 May 18;140(10):823-30. https://doi.org/10.7326/0003-4819-140-10-200405180-00010 PMid:15148067
Klein EY, Sun L, Smith DL, Laxminarayan R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol. 2013 Sep 1;177(7):666-74. https://doi.org/10.1093/aje/kws273 PMid:23449778
Broex ECJ, Van Asselt ADI, Bruggeman CA, Van Tiel FH. Surgical site infections: how high are the costs? J Hosp Infect. 2009 Jul;72(3):193-201. https://doi.org/10.1016/j.jhin.2009.03.020 PMid:19482375
David MZ, Siegel J, Lowy FD, Zervos MJ, Clemenston JS. Methicillin-resistant Staphylococcus aureus infections in healthcare settings. N Engl J Med. 2012 Apr;367(7):640-9. https://doi.org/10.1056/NEJMra1201533 PMid:23738546 PMCid:PMC3777557
Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009 Sep;7(9):629-41. PMID:19680247.https://doi.org/10.1038/nrmicro2200 PMid:19680247 PMCid:PMC2871281
Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005 May;5(5):275-86.https://doi.org/10.1016/S1473-3099(05)70112-2 PMid:15854883
David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010 Jul;23(3):616-87. https://doi.org/10.1128/CMR.00081-09 PMid:20610826 PMCid:PMC2901661
Otter JA, French GL. Community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011 Jan;79(3):189-93. https://doi.org/10.1016/j.jhin.2011.05.014 PMid:21764173
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 1;52(3):e18-55. https://doi.org/10.1093/cid/ciq146 PMid:21208910
Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005 Apr 7;352(14):1436-44. https://doi.org/10.1056/NEJMoa043252 PMid:15814879
Gosselin RC, Corkill JE, Anson JG, Woodford N, Livermore DM. Antibiotic resistance among Gram-positive cocci: surveillance findings in orthopaedic infections. J Chemother. 2011 Aug;23(4):230-6. PMID:21787269. doi:10.1179/joc.2011.23.4.230.
Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, Garber G. Varying estimates of methicillin-resistant Staphylococcus aureus (MRSA) burden and transmission in the hospital setting: a systematic review. BMC Infect Dis. 2016 Apr 18;16:150. PMID:27086788. doi:10.1186/s12879-016-1470-5.
Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008 May 1;46(6):787-94. https://doi.org/10.1086/527394 PMid:18230044
Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 2010 Nov 11;15(41):19688. https://doi.org/10.2807/ese.15.41.19688-en PMid:20961515
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):e132-73. https://doi.org/10.1093/cid/cis346 PMid:22619242
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Usha Rani Vadlamanu MD, Dr. Sujatha Pambi MD, Dr. Chandrasekhar BM MS, Dr. Keshava Rao Bolloju

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.